Sustained expression of CD154 (CD40L) and proinflammatory cytokine production by alloantigen-stimulated umbilical cord blood T cells

Journal of Immunology

Volumn 164, Issue 12, 2000, Pages 6206-6212

  Matthews, Nick C ^a   Wadhwa, Meenu ^b   Bird, Chris ^b   Borras, Francesc E ^a   Navarrete, Cristina V ^a,c  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; ARTICLE; CELL TRANSPLANTATION; CYTOKINE PRODUCTION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

EID: 0034660110     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.12.6206     Document Type: Article

References (45)

1. Kurtzberg, J., M. Laughlin, M. L. Graham, C. Smith, J. F. Olsen, E. C. Halperin, G. Ciocci, C. Carrier, C. E. Stevens, and P. Rubenstein. 1996. Placental blood as a source of hematopoeitic stem cells for transplantation into unrelated recipients. New. Engl. J. Med. 335:157.
2. Rubenstein, P., A. Scaradavou, J Kurtzberg, J. Adamson, A. R. Migliaccio, R. L. Berkowitz, M. Cabbad, N. L. Dobrila, P. E. Taylor, R. E. Rosenfield, and C. E. Stevens. 1998. Outcomes among 562 recipients of placental blood transplants from unrelated donors. New. Engl. J. Med. 339:1565.
3. Locatelli, F., V. Rocha, C. Chastang, W. Arcese, G. Michel, M. Abecasis, C. Messina, J. Ortega, I. Badell-Serra, E. Plouvier, et al. 1999. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Blood 93:3662.
4. Barrett, A. J. 1989. Graft versus host disease, clinical and biological features. Bone Marrow Transplant. 4(Suppl. 4):18.
5. Risdon, G., J. Gaddy, F. B. Stehman, and H. E. Broxmeyer. 1994. Proliferative and cytotoxic responses of human CB T lymphocytes following allogeneic stimulation. Cell Immunol. 154:14.
6. Harris, D. T., J. LoCascio, and F. J. Besencon. 1994. Analysis of the alloreactive capacity of human umbilical cord blood: implications for graft-versus-host disease. Bone Marrow Transplant. 14:545.
7. Grewal, I. S., and R. A. Flavell. 1996. The role of CD40 ligand in costimulation and T cell activation. Immunol. Rev. 153:85.
8. Horner, A. A., H. Jabara, N. Ramesh, and R. S. Geha. 1995. γδ T lymphocytes express CD40 ligand and induce isotype switching in B lymphocytes. J. Exp. Med 181:1239.
9. Desai-Mehta, A., L. Lu, R. Ramsey-Goldman, and S. K. Datta. 1996. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic auloantibody production. J. Clin. Invest. 97:2063.
10. Saeland, S., V. Duvert, I. Moreau, and J. Banchereau. 1993. Human B cells proliferate and express CD23 after CD40 ligation. J. Exp. Med. 178:113.
11. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747.
12. + T cell mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation. J. Immunol. 158:29.
13. + T cells tolerized ex vivo to host alloantigens by anti-CD40 ligand (CD40L:CD154) antibody lose graft-versus-host disease lethality but retain nominal antigen responses. J. Clin. Invest.102:473.
14. Durandy, A., G. De Saint Basille, B. Lisowska-Grospierre, J. F. Gauchat, M. Forveille, R. A. Kroczek, J. Y. Bonnefoy, and A. Fischer. 1995. Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns. J. Immunol 154:1560.
15. Nonoyama, S., L. A. Penix, C. P. Edwards, D. B. Lewis, S. Ito, A. Aruffo, C. B. Wilson, and H. D. Ochs. 1995. Diminished expression of CD40 ligand by activated neonatal T cells. J. Clin. Invest. 95:66.
16. Splawski, J. B., J. Nishioka, Y. Nishioka, and P. E. Lipsky. 1996. CD40 Ligand is expressed and functional on activated neonatal T cells. J. Immunol. 156:119.
17. + T-helper and a T-killer cell. Nature 393: 474.
18. Bennett, S. R., F. R. Carbine, F. Caramels, R. A. Flavell, J. F. Miller, and W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478.
19. Hart, D. N. J. 1997. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90:3245.
20. Steinman, R. M. 1991. The dendritic cell and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
21. Ridge, J. P., E. J. Fuchs, and P. Matzinger. 1996. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271:1723.
22. Eljaafari, A., K. Duperrier, S. Mazet, C. Bardin, J. Bernaud, B. Durand, L. Gebuhrer, H. Betuel, and D. Rigal. 1998. Generation of stable monocyte-derived dendritic cells in the presence of high concentrations of homologous or autologous serum: influence of extracellular pH. Hum. Immunol. 59:625.
23. Lyons, A. B., and C. R. Parish. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171:131.
24. Meager, A. 1991. A cytotoxicity assay for tumour necrosis factor using a human rhabdomyosarcoma cell line. J. Immunol. Methods 144:141.
25. Wadhwa, M., C. Bird, L. A. Page, A. R. Mire-Sluis, and R. Thorpe. 1995. Quantitative biological assays for cytokines. In Cytokines - A Practical Approach, 2nd Ed. F. R. Balkwill, ed. Oxford University Press, Oxford, p. 375.
26. Shlomchik, W. D., M. S. Couzens, C. B. Tang, J. McNiff, M. E. Robert, J. Liu, M. J. Shlomchik, and S. G. Emerson. 1999. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285:412.
27. + T cells enables preservation of a naive repertoire. J. Immunol. 161:5909.
28. Rissoan, M.-C., V. Soumelis, N. Kadowaki, G. Grouard, F. Briere, R. de Waal Malefyt, and Y.-J. Lun. 1999. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283:1183.
29. Kelsall, B. L., E. Stüber, M. Neurath, and W. Strober. 1996. Interleukin-12 production by dendritic cells: the role of CD40-CD154 interactions in Th1 T cell responses. Ann. NY Acad. Sci. 795:116.
30. Peng, X., J. E. Remade, A. Kasran, D. Huylebroeck, and J. L. Ceuppens. 1998. IL-12 upregulates CD40 ligand (CD154) expression on human T cells. J. Immunol. 160:1166.
31. Hirohata, S. 1999. Human Th1 responses driven by IL-12 are associated with enhanced expression of CD40 ligand. Clin. Exp. Immunol. 115:78.
32. Lane P., A. Traunecker, S. Hueble, S. Inui, A. Lanzavecchia, and D. Gray. 1992. Activated T cells express a ligand for the human B cell associated antigen CD40 which participates in T cell dependent activation of B lymphocytes. Eur. J. Immunol. 22:2573.
33. + T cells with dendritic cells. Eur. J. Immunol. 26:3137.
34. Maxwell, J. R., J. D. Campbell, C. H. Kim, and A. T. Wella. 1999. CD40 activation boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying peripheral T cell deletion. J. Immunol. 162:2024.
35. Johnson-Leger, C., J. Christensen, and G. G. Klaus. 1998. CD28 cotimulation stabilizes the expression of the CD40 ligand on T cells. Int. Immunol. 10:1083.
36. Liu, Z., S. Tugulea, R. Caortesini, S. Lederman, and N. Suciu-Foca. 1999. Inhibition of CD40 signalling pathway in antigen presenting cells by T suppresser cells. Hum. Immunol. 60:568.
37. Hermann, P., C. Van-Kooten, C. Gaillard, J. Banchereau, and D. Blanchard. 1995. CD40 ligand positive CD8 T cell clones allow B cell growth and differentiation. Eur. J. Immunol. 25:2972.
38. + T cells achieve a lower magnitude of activation when compared with their adult counterparts. Immunology 90:397.
39. Katamura, K., Y. Tabata, Y. Oshima, N. Shintaku, Y. Yamauchi, and M. Mayumi. 1995. Selective induction of interleukin-4 and interferon-γ producing T cells from cord blood naive T cells: effects of costimulatory signalling through CD28. Int. Arch. Allergy. Immunol. 106:101.
40. + T cells. J. Exp. Med. 186:1407.
41. + T cells requires CD154 expression by Th cells in acute graft-versus-host disease. J. Immunol. 162:4373.
42. Nüsslein, H. G., K. H. Frosch, W. Woith, P. Lane, J. R. Kalden, and B. Manger. 1996. Increase of intracellular calcium is the essential signal for the expression of CD40 ligand. Eur. J. Immunol. 26:846.
43. 2+/calmodulin kinase type IV/Gr and calcineurin. J. Immunol. 162:2057.
44. 2+ responses triggered in T cells compared with B cells. J. Exp. Med. 188:1473.
45. Lin, M. T., L-H. Tseng, J. Pei, M. Garcia, A. Barsoukov, Y. Akatsuka, and J. Hansen. 1997. Cell death among peripheral blood T cells following allogeneic marrow transplantation: correlation with markers of activation. Blood 90(Suppl.): 2410.